Profile
Gerard Chia is currently a Board Member at ViAqua Therapeutics Ltd. since 2018 and a Partner at Clay Capital since 2019.
Former roles include Analyst at Aquilus Pte.
Ltd. from 2012 to 2016 and Investment Analyst at PT Saratoga Capital.
Education includes an undergraduate degree from the University of London.
Gerard Chia active positions
| Companies | Position | Start |
|---|---|---|
Clay Capital
Clay Capital Investment ManagersFinance Clay Capital invests in companies located across Europe and Asia. The firm focuses on the food & agritech sectors. It provides financing for seed to series C capital requirements. | Private Equity Investor | 01/01/2015 |
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops orally administered supplements in aquaculture to prevent viral epidemics | Director/Board Member | 01/01/2018 |
Former positions of Gerard Chia
| Companies | Position | End |
|---|---|---|
Aquilus Pte. Ltd.
Aquilus Pte. Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 31/01/2016 |
PT Saratoga Capital
PT Saratoga Capital Financial ConglomeratesFinance Alternative investment manager | Corporate Officer/Principal | - |
Training of Gerard Chia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aquilus Pte. Ltd.
Aquilus Pte. Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
PT Saratoga Capital
PT Saratoga Capital Financial ConglomeratesFinance Alternative investment manager | Finance |
Clay Capital
Clay Capital Investment ManagersFinance Clay Capital invests in companies located across Europe and Asia. The firm focuses on the food & agritech sectors. It provides financing for seed to series C capital requirements. | Finance |
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops orally administered supplements in aquaculture to prevent viral epidemics | Health Technology |
- Stock Market
- Insiders
- Gerard Chia
















